$RNGE
RANGE IMPACT, INC. Stock $rnge

$rnge Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017381 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$3.998M	$3.015M	$0.00
YoY Change	525.36%
Cost Of Revenue	$3.153M	$2.366M
YoY Change	448.94%
Gross Profit	$845.1K	$649.0K
YoY Change	1201.12%
Gross Profit Margin	21.14%	21.53%
Selling, General & Admin	$635.9K	$726.1K	$317.9K
YoY Change	67.2%	128.36%	-45.85%
% of Gross Profit	75.25%	111.87%
Research & Development	$107.4K	$106.2K	$125.7K
YoY Change	-0.35%	-15.55%	77.99%
% of Gross Profit	12.71%	16.36%
Depreciation & Amortization	$341.7K	$354.2K	$0.00
YoY Change	516.95%
% of Gross Profit	40.44%	54.57%
Operating Expenses	$743.3K	$832.2K	$443.7K
YoY Change	52.28%	87.58%	-32.56%
Operating Profit	$101.8K	-$183.2K	-$443.7K
YoY Change	-124.05%	-58.7%
Interest Expense	$65.00K	$43.64K	-$4.300K
YoY Change	225.16%	-1114.81%
% of Operating Profit	63.87%
Other Income/Expense, Net	-$65.00K	-$43.64K	$0.00
YoY Change	225.16%		-100.0%
Pretax Income	$36.76K	-$226.9K	-$448.0K
YoY Change	-108.29%	-49.36%	24.22%
Income Tax
% Of Pretax Income
Net Earnings	$36.76K	-$226.9K	-$448.0K
YoY Change	-108.29%	-49.36%	24.22%
Net Earnings / Revenue	0.92%	-7.52%
Basic Earnings Per Share	$0.00	$0.00	-$0.01
Diluted Earnings Per Share	$0.00	$0.00	-$8.707K
COMMON SHARES
Basic Shares Outstanding	80.85M shares	78.12M shares	51.45M shares
Diluted Shares Outstanding	80.52M shares	78.12M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$359.6K	$229.0K	$44.16K
YoY Change	-80.73%	418.61%	-95.01%
Cash & Equivalents	$359.6K	$229.0K	$44.16K
Short-Term Investments
Other Short-Term Assets	$47.72K	$880.00	$880.00
YoY Change	-80.98%	0.0%	-72.5%
Inventory
Prepaid Expenses	$47.72K	$884.00
Receivables	$1.274M	$1.234M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.810M	$1.463M	$45.05K
YoY Change	-5.22%	3148.47%	-94.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.134M	$6.438M
YoY Change	265.03%
Goodwill	$751.4K	$751.4K
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$19.98K	$8.890K	$8.890K
YoY Change	124.75%	0.0%	-6.42%
Total Long-Term Assets	$6.906M	$7.198M	$8.890K
YoY Change	169.67%	80865.91%	-6.42%
TOTAL ASSETS
Total Short-Term Assets	$2.810M	$1.463M	$45.05K
Total Long-Term Assets	$6.906M	$7.198M	$8.890K
Total Assets	$9.715M	$8.661M	$53.94K
YoY Change	75.84%	15957.29%	-93.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$772.9K	$1.034M	$133.6K
YoY Change	40.85%	674.56%	299.37%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.200M	$100.0K	$750.0K
YoY Change	41.18%	-86.67%
Long-Term Debt Due	$1.090M	$1.025M
YoY Change	177.43%
Total Short-Term Liabilities	$3.062M	$2.160M	$883.6K
YoY Change	70.95%	144.44%	2542.19%
LONG-TERM LIABILITIES
Long-Term Debt	$3.458M	$3.789M	$0.00
YoY Change	299.44%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$3.458M	$3.789M	$0.00
YoY Change	175.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.062M	$2.160M	$883.6K
Total Long-Term Liabilities	$3.458M	$3.789M	$0.00
Total Liabilities	$6.520M	$5.949M	$883.6K
YoY Change	113.91%	573.27%	2542.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$50.40M	-$50.44M
YoY Change	0.74%
Common Stock	$53.60M	$53.15M
YoY Change	2.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.195M	$2.713M	-$829.6K
YoY Change
Total Liabilities & Shareholders Equity	$9.715M	$8.661M	$53.94K
YoY Change	75.84%	15957.29%	-93.99%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$36.76K	-$226.9K	-$448.0K
YoY Change	-108.29%	-49.36%	24.22%
Depreciation, Depletion And Amortization	$341.7K	$354.2K	$0.00
YoY Change	516.95%
Cash From Operating Activities	-$1.074M	$675.8K	-$394.2K
YoY Change	138.24%	-271.44%	-29.27%
INVESTING ACTIVITIES
Capital Expenditures	$38.29K	$746.2K
YoY Change	-103.46%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$38.29K	-$746.2K
YoY Change	-97.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$626.1K
YoY Change
Cash From Financing Activities	1.243M	-$142.9K	400.0K
YoY Change	-69.79%	-135.73%
NET CHANGE
Cash From Operating Activities	-1.074M	$675.8K	-394.2K
Cash From Investing Activities	-38.29K	-$746.2K
Cash From Financing Activities	1.243M	-$142.9K	400.0K
Net Change In Cash	130.5K	-$213.4K	5.820K
YoY Change	-92.84%	-3765.82%
FREE CASH FLOW
Cash From Operating Activities	-$1.074M	$675.8K	-$394.2K
Capital Expenditures	$38.29K	$746.2K
Free Cash Flow	-$1.112M	-$70.43K	-$394.2K
YoY Change	-269.34%	-82.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001438943
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q1	us-gaap	Gross Profit GrossProfit		usd
CY2022Q1	us-gaap	Depreciation Depreciation		usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2023Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P6Y
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2023Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments		usd
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	MLCT	Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged		shares
CY2023Q1	MLCT	Share Based Compensation Arrangements By Share Based Payment Award Options Exchanged In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExchangedInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Depreciation Depreciation		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-53832
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	MALACHITE INNOVATIONS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-3268988
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	200 Park Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 400
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Cleveland
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44122
CY2023Q1	dei	City Area Code CityAreaCode	(216)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	304-6556
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q1	dei	Trading Symbol TradingSymbol	MLCT
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80850148	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	229018	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	442369	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1233532	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	981385	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	884	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	884	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1463434	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1424638	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6437556	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6045514	usd
CY2023Q1	us-gaap	Goodwill Goodwill	751421	usd
CY2022Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8892	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8892	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	7197869	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6805827	usd
CY2023Q1	us-gaap	Assets Assets	8661303	usd
CY2022Q4	us-gaap	Assets Assets	8230465	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1034427	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	233808	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1025362	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1319201	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	100000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2159789	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1553009	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3788931	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3738013	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3788931	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3738013	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5948720	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5291022	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78116814	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78116814	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78116814	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78116814	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	78117	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	78117	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	53074180	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	53074180	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50439714	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50212854	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2712583	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2939443	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8661303	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8230465	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3014887	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	2365885	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	649002	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	726048	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	317941	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	106177	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	125730	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	832225	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	443671	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-183223	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	4303	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-443671	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	43637	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-43637	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4303	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-226860	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-447974	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78116814	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51450147	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2939443	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-226860	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2712583	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2712583	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-381641	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-381641	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-447974	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-829615	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-829615	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-226860	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-447974	usd
CY2023Q1	us-gaap	Depreciation Depreciation	354184	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	252147	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	800619	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	50993	usd
CY2022Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	200	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	675796	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-394181	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	746226	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-746226	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	383202	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	626123	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	100000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	400000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-142921	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	400000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-213351	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5819	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	442369	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	38343	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	229018	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	44162	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	43637	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	4303	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-226860	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	675796	usd
CY2023Q1	us-gaap	Substantial Doubt About Going Concern Conditions Or Events SubstantialDoubtAboutGoingConcernConditionsOrEvents	The Company estimates, as of March 31, 2023, that it has sufficient funds to operate the business for 12 months given its cash balance of $229,018, line of credit availability of $900,000, and revenues being generated by the Range Reclamation Entities.
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	229018	usd
CY2023Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	900000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zFGkhx3NimEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31705879	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31705879	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31705879	shares
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1233532	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	981385	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7384039	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6637814	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	946483	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	592300	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6437556	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6045514	usd
CY2023Q1	us-gaap	Depreciation Depreciation	354184	usd
CY2022	us-gaap	Depreciation Depreciation	395543	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31705879	shares
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segment
CY2023Q1	us-gaap	Goodwill Goodwill	751421	usd
CY2022Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2022Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	751421	usd
CY2023Q1	us-gaap	Goodwill Goodwill	751421	usd
CY2022Q4	us-gaap	Goodwill Goodwill	751421	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9392544	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.54
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9392544	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.54
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9392544	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.54
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9392544	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q1	MLCT	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableNumber	9392544	shares
CY2023Q1	MLCT	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue	0	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2023-11-30
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.01	pure
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	100000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	The debt matures from 2023 through 2028.
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	1025362	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	1136102	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	835671	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	754233	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	679880	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	383045	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	4814293	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	5	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3014887	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	649002	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-226860	usd
CY2023Q1	us-gaap	Assets Assets	8661303	usd
CY2023Q1	us-gaap	Depreciation Depreciation	354184	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	43637	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	746226	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-447974	usd
CY2022Q1	us-gaap	Assets Assets	53938	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	4303	usd

Files In Submission

Name	View Source	Status
0001493152-23-017381-index-headers.html	Edgar Link	pending
0001493152-23-017381-index.html	Edgar Link	pending
0001493152-23-017381.txt	Edgar Link	pending
0001493152-23-017381-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mlct-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mlct-20230331_cal.xml	Edgar Link	unprocessable
mlct-20230331_def.xml	Edgar Link	unprocessable
mlct-20230331_lab.xml	Edgar Link	unprocessable
mlct-20230331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RNGE
RANGE IMPACT, INC. Stock $rnge

2023 Q2 Form 10-Q Financial Statement

#000149315223017381 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNGE RANGE IMPACT, INC. Stock $rnge

2023 Q2 Form 10-Q Financial Statement

#000149315223017381 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RNGE
RANGE IMPACT, INC. Stock $rnge